ChroMedX Completes Proof-of-Concept CO-Oximetry and Bilirubin Prototype Development
ChroMedX Corp.(the "Company"), a developer of in vitro diagnostics and point-of-care testing (POCT) devices is pleased to report the development of a proof-of-concept prototype of the Company's HemoPalm(TM) analyzer and associated cartridge for measuring CO-oximetry and bilirubin*.
View full press release